Welcome Welcome Welcome Welcome Welcome v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v
The Aspirin Foundation helps to increase awareness and medical research interest in this vitally important medicine by stimulating the distribution and exchange of information and discussion on all aspects of Aspirin, including current research as well as old and new therapeutic uses for it.
The Aspirin Foundation is guided by an independent International Scientific Advisory Board.
NSAIDs and COVID-19
Professor Garret FitzGerald MD FRS, from the Institute for Translational Medicine and Therapeutics at the University of Philadelphia, has given some logical scientific guidance regarding the use of regular medication such as NSAIDS and ACE inhibitors during the COVID-19 pandemic.
For further information please see:
FitzGerald GA. Misguided drug advice for COVID-19. Science 2020 March 20th letters 10.1126/science.abb8034 https://science.sciencemag.org/content/early/2020/03/20/science.abb8034
The FDA [19th March 2020] and the EMA [18th March 2020] have released statements explaining that there is no current scientific evidence to connect NSAIDS with worsening COVID-19. Both agencies continue to monitor the situation. The full statements can be read below:
Entries open for the International Aspirin Foundation's Emerging Aspirin Investigator Award 2020
Deadline for applications : 31st May 2020
Supported by GL Pharma GmbH, the winning entrant will receive a £1000 endowment plus a travel and accommodation bursary.
A report will be produced to highlight the winning entry, together with a summary of the candidate’s work, and the successful applicant should be available to present their work during an Award Ceremony in the prestigious Ether Dome Amphitheatre at Massachusetts General Hospital, Boston on 28th September 2020.
Applications are now open for the International Aspirin Foundation's Senior Science Award 2020.
Deadline for applications : 31st March 2020
Professor Carlo Patrono, MD, FESC, FRCP, Chair of the International Aspirin Foundation’s Scientific Advisory Board will
lead the judging process. He said: “The Senior Science Award is a recognition of those scientists who have contributed innovative
basic or clinical research elucidating mechanistic and/or therapeutic aspects of aspirin's multifaceted benefits. We welcome entries from
individuals and groups with a record of outstanding biomedical research that has advanced the scientific knowledge of aspirin and its
impact on human health, and look forward to celebrating the best in the field.”
Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention
Long term low- dose aspirin use in patients with chronic viral hepatitis reduces the risk of HCC and liver related mortality.